Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

20. September 2023 05:33 ET | Quelle: Transparency Market Research

Thyroid Function Test Market Size to Hit USD 2.6 billion by 2031, Expanding at a CAGR of 5.4% - Exclusive Report by Transparency Market Research

Wilmington, Delaware, United States, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global thyroid function test market is projected to flourish at a CAGR of 5.4% from...
18. März 2021 08:30 ET | Quelle: Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference

CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and...
22. Mai 2020 12:35 ET | Quelle: Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals, Inc. Announces Expected Closing of Merger Transaction with Qualigen, Inc.

LOS ANGELES, May 22, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals”, “Ritter” or the “Company”), today announced that its pending merger transaction...
06. Mai 2020 09:15 ET | Quelle: Ritter Pharmaceuticals, Inc.

Leading Independent Proxy Advisory Firms Recommend Ritter Pharmaceuticals Shareholders Vote in Favor of its Merger and Each of the Merger Proposals

LOS ANGELES, May 06, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), today announced that Institutional Shareholder Services Inc....
16. April 2020 14:07 ET | Quelle: Ritter Pharmaceuticals, Inc.

Ritter Pharmaceuticals, Inc. Announces Form S-4 Registration Statement Declared Effective by SEC

Special Meeting of Ritter Pharmaceuticals, Inc. Stockholders to Vote on Proposed Merger Scheduled for May 14, 2020 LOS ANGELES , April 16, 2020 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc....